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Abstract
Purpose To investigate unmet needs of patients with colorectal cancer (CRC) at the end of treatment and whether unmet needs
improve over time. Identify predictors of need following treatment and whether unmet need is associated with worse health-
related quality of life (HRQoL).
Methods As part of the UK ColoREctal Wellbeing (CREW) cohort study, patients treated for CRC completed the Supportive Care
Needs Survey Short Form-34 (SCNS SF-34) 15 and 24 months following surgery, along with questionnaires measuring HRQoL,
wellbeing, life events, social support, and confidence to manage their cancer before surgery, 3, 9, 15, and 24 months post-surgery.
Results The SCNS SF-34 was completed by 526 patients at 15 months and 510 patients at 24 months. About one-quarter of
patients had at least one moderate or severe unmet need at both time points. Psychological and physical unmet needs were the
most common and did not improve over time. Over 60% of patients who reported 5 or more moderate or severe unmet needs at
15 months experienced the same level of unmet need at 24 months. HRQoL at the beginning of treatment predicted unmet needs
at the end of treatment. Unmet needs, specifically physical, psychological, and health system and information needs, were
associated with poorer health and HRQoL at the end of treatment.
Conclusions Unmet needs persist over time and are associated with HRQoL. Evaluation of HRQoL at the start of treatment
would help inform the identification of vulnerable patients. Assessment and care planning in response to unmet needs should be
integrated into person-centred care.
Implications for Cancer Survivors Early identification of CRC patients at risk of unmet needs will help infrom personalised
survivorship care plans. The implementation of personalised and tailored services are likely to confer HRQoL gains.
Keywords Colorectal cancer . Supportive care needs . Health-related quality of life . Survivorship
Introduction
The experience of cancer and its treatment from the per-
spective of the patient is increasingly recognised as an
integral part of health outcome assessment [1]. Patient-
reported outcome measures (PROMs) focused on health-
related quality of life (HRQoL) and satisfaction of care
and needs, and collect information on physical or psycho-
social problems that might otherwise be overlooked [2].
This information can be used to tailor treatment and care
and has the potential to improve clinical outcomes [3–5].
Given that the physical and psychosocial impact of cancer
and its treatment can be felt long after active treatment has
been completed [6], it is important that patient-reported
assessments continue beyond treatment.
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The number of people living with and beyond cancer treat-
ment is increasing and is predicted to reach 4 million in the
UK by 2030 [7]. People living beyond colorectal cancer
(CRC) form the largest group of survivors of cancer affecting
men and women [8]. With improvements in early diagnosis
and treatment, 76% of people in England diagnosed with CRC
now survive a year and 57% 5 years [9]. The standard treat-
ment pathway for CRC is surgery, with the addition of adju-
vant chemotherapy for patients with Dukes’ C/high-risk
Dukes’B, neoadjuvant radio and/or chemotherapy for patients
with rectal cancer, and neoadjuvant chemotherapy for patients
with operable liver metastases. The rate of permanent stoma
formation after rectal cancer surgery varies considerably and
ranges from 9 to 50% across England [10].
A review of the difficulties encountered by people living
5 years post-cancer diagnosis found that 20–30% of survivors
consistently reported problems associated with cancer and its
treatment including physical problems, psychological distress,
sexual problems, problems with relationships, and financial
concerns [11]. Problems specifically affecting CRC survivors
include the long-term physical and psychosocial effects of al-
tered bowel function and stoma placement [12, 13]. Given finite
resources, these problems might not be recognised or managed.
Unmet needs have been identified as one of the four main
gaps in knowledge about the problems experienced by cancer
survivors [14]. In addition, identification of survivors with the
greatest needs may be important for developing appropriate and
effective long-term survivorship care plans. Although there are
several cancer-specific needs assessments designed for use with
patients living with and beyond cancer [15–20], there is limited
research into perceived unmet needs of patients, particularly
within the early survivorship phase and change in needs over
time [21, 22]. A review of patients’ needs assessment tools [23]
identified the Supportive Care Needs Survey (SCNS) [16] as
one of the most comprehensive instruments with respect to
covering needs across the multi-dimensional aspects of health
status as well as satisfaction. The SCNS assesses the perceived
needs of people living with cancer, whether they remain unmet
and the magnitude of such needs.
Armes et al. used the SCNS to investigate the supportive
care needs of patients at the end of treatment for various can-
cer types including CRC and suggested that as many as half of
cancer survivors might experience some form of unmet need,
with psychological needs particularly flagged as inadequately
met [21]. In addition, they found evidence for persistence in
unmet needs over a 6-month period with no improvement in
unmet needs for 60% of patients who had more than 5 unmet
needs at the end of treatment [21]. Lam et al. also reported
similar findings of prolonged unmet needs in CRC patients
from the point of diagnosis to 12 months post-surgery [24].
Predictors of unmet need in cancer patients have been iden-
tified as age [25], active or advanced disease [16, 26], negative
mood, other significant life events [20, 27–31], cancer-related
rumination [24], educational attainment [24], low levels of
social support (emotional or informational support and posi-
tive social interaction) [26], personality [32], low levels of
physical activity [26], and maladaptive coping strategies such
as anxious preoccupation, hopeless/helplessness, and avoid-
ance [26]. However, previous studies only considered a small
number of potential predictors.
This limitation was addressed by the UK ColoREctal
Wellbeing study (CREW), a large-scale prospective cohort
study investigating factors associated with recovery of health
and wellbeing following a diagnosis of CRC [33]. The CREW
domains of assessment were informed by a conceptual frame-
work of recovery following cancer diagnosis and treatment
[34] which hypothesises that a number of factors, including
the supportive care needs of patients, influence the course of
recovery. CREW used the SCNS Short Form 34 (SF-34) [16]
to measure patient-perceived unmet needs at 15 months and
24 months following surgery, at which time any adjuvant
treatment would have ended. The rationale for selecting these
time points was that needs might be heightened during the
transition period between active treatment and the recovery
phase as clinician involvement in care declines and patients
find themselves having to self-manage their condition.
The main aim of this paper is to describe patient-reported
unmet needs after treatment for CRC and 9 months later. In
particular, to investigate any change in perceived needs over
time and to predict which individuals are more likely to have
unmet needs at the end of treatment. A secondary aim was to
investigate associations between unmet need following treat-
ment and HRQoL outcomes, with the hypothesis that high
unmet needs are associated with poorer recovery of health
and wellbeing.
Method
Study design and participants
CREW is a multicentre, prospective cohort study of newly
diagnosed patients with CRC, treated with curative intent in
29 cancer centres across the UK. Patients were eligible if they
(a) had a diagnosis of non-metastatic CRC (Dukes’ A–C), (b)
were awaiting primary surgery with curative intent (patients
who had been identified as eligible and admitted for emergen-
cy surgery were also included), (c) ≥ 18 years old, and (d) had
the ability to complete questionnaires. Recruitment took place
between November 2010 and March 2012; the aim was to
include every eligible patient diagnosed at each cancer centre
during the centre’s recruitment period. Further details relating
to eligibility, recruitment strategy, and sample size are provid-
ed elsewhere [33].
Written consent was obtained and baseline questionnaires
completed prior to surgery whenever possible. Socio-
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demographic information including gender, age, ethnicity,
employment, and domestic status was also collected at con-
sent. Clinical details including tumour site (colon, rectum),
Dukes’ stage (A, B, C1, and C2), and treatment (neoadjuvant,
adjuvant, and stoma formation) were extracted from medical
records at 6 months and verified at 24 months post-surgery.
Self-reported comorbidities were recorded from 3 months
post-surgery.
Patient self-report questionnaires also measured a broad
range of issues including supportive care needs, life events
(e.g. spousal/relational problems, bereavement, financial
problems), health status, HRQoL, wellbeing, social support,
and self-efficacy. Follow-up mailed questionnaires were com-
pleted at 3, 9, 15, and 24 months post-surgery (longer term
data collection continued for up to 5 years).
The study was approved by the UK National Health
Service National Research Ethics Service (REC reference
number: 10/H0605/31).
Measures
Full details of the repeated measures used in the CREW study
are provided elsewhere [33].
Unmet needs
The SCNS SF-34 [16] was used to assess perceived needs and
whether they had been met at 15- and 24-month follow-up
points. The scale includes 34 items covering five domains of
need: physical/daily living, psychological, sexuality, patient
care and support, and health system and information. Each
need is rated on a 5-point Likert-type scale with responses 1
(“Not applicable” or “No need”) and 2 (“Need satisfied”) in-
dicating no outstanding need while 3, 4, and 5 measure degree
of unmet need ranging from “Low” (little need for additional
help) to “High” (strong need for additional help).
Life events
The incidence of significant life events in the past 6 months
was recorded from 3-month follow-up using a modified ver-
sion of the list of threatening life experiences [35], with death
of a spouse and child presented as separate life events and
death of a pet and moving house added.
Health status, HRQoL, and wellbeing
The EuroQol 3-level version (EQ-5D-3L) [36] measures ge-
neric health status across five domains: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression each
scored as none/some/severe problems.
The Quality of Life of Adult Cancer Survivors (QLACS)
Scale Part 1 [37] measures 28 QoL issues across eight generic
domains which are not necessarily attributable to cancer: neg-
ative feelings, positive feelings, cognitive problems, pain, sex-
ual interest and sexual function (merged together), energy/fa-
tigue, and social avoidance.
The European Organisation for Research and Treatment of
Cancer (EORTC) 30-item Core measure (QLQ-C30) [38] and
the CRC module (QLQ-CR29) [39] were included from
3 months onwards. The QLQ-C30 includes five functional
scales, three symptom scales, six single items, and a Global
health status/QoL scale. The QLQ-CR29 supplements the
QLQ-C30 with 29 colorectal cancer-specific items, from
which are derived four functional subscales (body image, anx-
iety, weight, and sexual interest) and 19 single item scales. A
linear transformation is applied to produce subscale scores
with a possible range from 0 to 100, with high scores indicat-
ing better functioning on the functional and Global health/
QoL scales but poorer symptoms on the symptom scales/
items.
The Personal Wellbeing Index–Adult (PWI-A) [40] in-
cludes eight items of satisfaction corresponding to standard
of living, health, achieving in life, relationships, safety, com-
munity connectedness, future security, and spirituality/
religion.
Anxiety and depression were assessed using the State-Trait
Anxiety Inventory (STAI) [41] and the Centre for
Epidemiologic Studies Depression Scale (CES-D) [42].
Positive and negative mood states were measured using 10
questions (5 questions for each mood state) from the Positive
and Negative Affect Scale (PANAS) [43].
Social support
The MOS Social Support Survey (MOS-SSS) [44] provides
an indication of how often different types of support are per-
ceived to be available including emotional/informational, tan-
gible, affectionate, and positive social interaction.
Self-efficacy
The Self-efficacy forManaging Chronic Disease Scale (Lorig)
[45] includes six items measuring confidence in different
areas.
Analysis
Univariate analysis of baseline characteristics of participants
was conducted using a chi-squared test to compare those who
completed at least one SCNS domain at 15 months with those
who did not. A multivariable logistic regression model was
additionally constructed to assess the differences once all sig-
nificant characteristics were mutually adjusted for (p < 0.05).
Independent variables were divided into five thematic
blocks: (1) socio-demographic characteristics (gender, age,
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employment, and domestic status), (2) clinical details (tumour
site, staging, treatment, stoma, co-morbidities), (3) psychoso-
cial measures (EQ-5D, QLACS-GSS, PWI-A, CES-D, STAI,
PANAS, MOS, Lorig), (4) cancer HRQoL (QLQ-C30), and
(5) CRC-specific HRQoL (QLQ-CR29). Due to a skewed
distribution in most of the psychosocial measures and
EORTC subscales, all scores, with the exception of QLACS-
GSS and the QLQ-C30 Global health/QoL score, were con-
verted into categorical covariates. See Supplementary
Material 1: Table 1.2, footnote 1 for details.
Descriptive measures were used to examine the prevalence
of total unmet supportive care needs. Consistent with previous
research on unmet needs [21], the number of participants with
no, few (1–4), and many (5 or above) moderate or severe
unmet needs was calculated. In terms of missing data, patients
were identified as having 5 or more unmet needs even if some
of the composite questions were missing (i.e. at least 5 were
rated as severe or moderate), otherwise the data were excluded
from the analysis. To investigate change in perceived needs
over time, a chi-squared test was used to test for differences
(marginal homogeneity) in the distribution of both overall and
SCNS domain unmet needs between the two time points of 15
and 24 months. In addition, the ten most common moderate/
severe unmet needs at 15 and 24 months post-surgery were
ranked and compared.
To predict which individuals are more likely to have
unmet needs at the end of treatment (15 months post-sur-
gery), logistic regression models were used to assess the
baseline predictors of unmet need for each SCNS domain.
In line with previous research using the SCNS [16, 21],
each SCNS domain of unmet needs was dichotomised
into no or low unmet need (score = 1 to 3) and moderate
or severe unmet need (score = 4 or 5). Independent vari-
ables were taken at the earliest time point available which
was at baseline except for the comorbidity status and the
EORTC measures (QLQ-C30 and QLQ-CR29), which
were first completed at 3 months. Therefore, we restricted
our sample to those respondents who participated at three
time points: baseline, 3 months, and 15 months. For each
SCNS domain, the final regression models were adjusted
for age as an important demographic effect-modifier.
To investigate the associations between the SCNS domains
of unmet need following treatment (15 months) and HRQoL
outcome (also at 15 months), an ordinary least squares (linear)
regressionmodel was produced. The QLQ-C30Global health/
QoL scale score at 15 months was preferred as the
(continuous) outcome measure since there was no evidence
against the assumption that the resulting residuals for the lin-
ear regression model were normally distributed. All five
SCNS domains (physical/daily living, psychological, sexual-
ity, patient care and support, and health system and informa-
tion) were the covariates of interest at 15 months and entered
into the model together. The model was adjusted for the socio-
demographic and clinical characteristics (Blocks 1–2, includ-
ing disease recurrence and negative life events). Blocks 3–5
were not included because of the hypothesised interaction
between these variables and supportive care needs.
Additional regression models were produced to explore the
association between each individual SCNS domain and
HRQoL outcome at 15 months, controlling for the significant
confounders.
Random clustering effects of cancer centre were assessed
by fitting centre separately as a fixed variable to each regres-
sion model and as a random effect. Both effects were negligi-
ble for all models; therefore, centre was not included in sub-
sequent models.
For all regression models, a forward stepwise selection
approach was used, which was applied in two steps: first,
separately to each thematic block of independent variables;
second, to the final set of those covariates which remained
significant in each block.
The significance level was fixed at 5% and analyses were
carried out using Stata Corp. StataSE 14 and IBM SPSS
Statistics 24.
Results
Characteristics of participants
Full details of the characteristics of the sample are provided
elsewhere [46].
At 15 months follow-up, 526 patients (70% of those who
gave a full consent at baseline) completed the SCNS as part of
their assessment. At 24 months follow-up, 510 (67% of base-
line completers) patients completed the SCNS with 448 (59%
of baseline completers) completing the measure at both time
points.
Completers and non-completers of the 15-month SCNS
were broadly similar in terms of baseline socio-
demographic and clinical characteristics (Supplementary
Material 1: Table 1.1), although non-completers were sig-
nificantly older and were more likely to be widowed or
single (p < 0.001). No significant differences were found
in the clinical characteristics of the participants by their
status of SCNS completion at 15 months (p > 0.05).
Difference in psychosocial characteristics and EORTC
subscales (Supplementary Material 1: Table 1.2) disap-
peared once age and domestic status of respondents were
controlled for in the multivariable model (Supplementary
Material 1: Table 1.3).
Unmet needs following treatment
The prevalence of unmet need at 15 months and
24 months post-surgery for each of the 34 items in the
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SCNS is available as supplementary material (see
Supplementary Material 2). At 15 months following sur-
gery, 24.9% of participants reported at least one moderate
or severe unmet need (score of 4 or 5), an additional
18.4% reported at least one low unmet need (score of 3)
and 46% patients reported no moderate or severe unmet
needs (scores of 1 or 2). Incomplete questionnaires meant
that 10.7% of participants could not be included in this
analysis. Unmet needs prevalence was similar at
24 months with 28.1% reporting at least one moderate
or severe unmet need. Figure 1 shows the prevalence of
moderate or severe needs at each time point, in terms of
those with many unmet needs (> 5) and those with fewer
unmet needs (< 4).
The prevalence of unmet needs according to the area of
need is shown in Table 1, with the most common moder-
ate or severe unmet needs across the two time points fall-
ing within the psychological domain. In terms of item
rankings shown in Table 2, fear of cancer spreading, re-
stricted activities, and lack of energy or tiredness were the
most prominent unmet needs at both time points.
Change in needs over time
Table 3 reports change in total unmet needs from 15 to
24 months. Of the 327 patients with no needs at 15 months,
49 (15%) went on to report at least one need at 24 months. Of
the patients who completed the SCNS at both time points, 54
patients reported having five or more moderate or severe un-
met needs at 15 months and 35 of these (63.6%) also reported
five or more unmet needs at 24 months. However, the chi-
squared test revealed no significant change in overall needs
between the two time points (p value < 0.05) and this was also
true for the change in SCNS domains over time (p values
presented in Table 1).
Baseline predictors of supportive care needs
after treatment
Since there was no significant change in unmet needs between
15 and 24 months, we selected the 15-month follow-up as-
sessment to model predictors of unmet need. The within-
blocks logistic regression models are available in
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Fig. 1 Moderate or severe unmet
needs at 15 months and
24 months post-surgery
Table 1 Number (percentage) participants at 15 months and 24 months expressing at least one moderate or severe unmet need across the SCNS
domains
Domain 15 months SCNS (526 completed) 24 months SCNS (510 completed) Chi-
squared
testAt least one moderate/
high unmet need
Missing data on all needs
for the domain
At least one moderate/
high unmet need
Missing data on all needs
for the domain
N (%) N (%) N (%) N (%) p value
Psychological 90 (17.1) 6 (1.1) 106 (20.8) 11 (2.2) 0.060
Physical and daily living 83 (15.8) 4 (0.8) 86 (16.9) 10 (2.0) 0.229
Sexuality 45 (8.6) 10 (1.9) 42 (8.2) 15 (2.9) 1.000
Patient care and support 40 (7.6) 3 (0.6) 43 (8.4) 5 (1.0) 0.618
Health system and
information needs
58 (11.0) 6 (1.1) 66 (12.9) 14 (2.7) 0.193
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SupplementaryMaterial 3. Table 4 presents the final multivar-
iable logistic regression models separately for each of five
SCNS domains.
While several socio-demographic, clinical, and psycho-
social characteristics place patients at greater risk of indi-
vidual unmet needs, HRQoL, as assessed by the QLQ-
C30 or QLQ-CR29, was predictive of unmet needs across
all SCNS domains. In particular, problems with body im-
age (QLQ-CR29 subscale) at baseline were predictive of
all unmet needs domains at 15 months. In addition, QLQ-
CR29 buttock pain was significantly associated with
physical, psychological, and sexuality unmet needs with
an odds ratio varying between 3.1 and 4.2 for the three
SCNS domains. At 15 months, unmet sexuality needs
were most prominent among patients with dysuria prob-
lems (QLQ-CR29) at baseline. Patients with blood or mu-
cus in the stools (QLQ-CR29) at baseline had on average
7 times higher odds of having unmet patient care and
support needs and health system and information needs.
Finally, patients with reduced role functioning (QLQ-C30
subscale) had 2–3 times higher odds of having high unmet
physical and psychological needs. With the exception the
measure of self-efficacy (Lorig), none of the psychosocial
measures (EQ-5D, QLACS-GSS, PWI-A, CES-D, STAI,
PANAS, MOS) were predictive of unmet need at the end
of treatment,
Association between Global health/QoL
and supportive care needs at 15 months
Supplementary Material 4 shows the variables from each
thematic block, which were significantly associated with
Table 2 Top 10 most prevalent
moderate or severe unmet needs
at 15 and 24 months following
surgery
Time point SCNS item Rank Moderate/severe unmet
need
Missing
N (%) N (%)
15 months
N = 526
Not being able to do the things you used to
do
1 59 (11.2) 8 (1.5)
Fears about the cancer spreading 2 50 (9.5) 16 (3.0)
Lack of energy/tiredness 3 48 (9.1) 14 (2.7)
Uncertainty about future 4 46 (8.7) 14 (2.7)
Concerns about the worries of those close to
you
5 44 (8.4) 14 (2.7)
Changes in sexual feelings 6 39 (7.4) 22 (4.2)
Changes in sexual relationships 7 35 (6.7) 21 (4.0)
Worry the results of treatment are beyond
your control
8 34 (6.5) 16 (3.0)
Work around home 9 32 (6.1) 20 (3.8)
Anxiety 10 31 (5.9) 19 (3.6)
24 months
N = 510
Fears about the cancer spreading 1 56 (11.0) 19 (3.7)
Not being able to do the things you used to
do
2 54 (10.6) 17 (3.3)
Lack of energy/tiredness 3 52 (10.2) 22 (4.3)
Anxiety 4 51 (10.0) 20 (3.9)
Feeling down or depressed 5 50 (9.8) 15 (2.9)
Concerns about the worries of those close to
you
6 49 (9.6) 15 (2.9)
Feelings of sadness 7 48 (9.4) 19 (3.7)
Uncertainty about future 8 43 (8.4) 16 (3.1)
Worry the results of treatment are beyond
your control
9 40 (7.8) 15 (2.9)
Pain 10 36 (7.1) 21 (4.1)
Table 3 Change in frequency of total unmet needs from 15 to
24 months
15 months 24 months
No needs 1–4 needs 5+ needs Total
N % N % N % N %
No needs 278 62.1 32 7.1 17 3.8 327 73.0
1–4 needs 29 6.5 26 5.8 12 2.7 67 15.0
5+ needs 13 2.9 6 1.3 35 7.8 54 12.1
Total 320 71.4 64 14.3 64 14.3 448 100
Excludes 24 months non-completers (chi-squared test p = 0.352)
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Global health/QOL (QLQ-C30) score at 15 months. When
separate regression models with each SCNS domain (as
the covariates of interest at 15 months) were generated, all
domains were significantly associated with Global health/
QOL. Independently from each other, each domain
remained significant after adjusting for the confounders
from Blocks 1–3 (see the models in Supplementary
Material 5). However, when the five SCNS domains were
entered into one model together, even without the con-
founders, only three domains remained statistically signif-
icant (physical and daily living needs, psychological
needs, and health system and information needs, see
Model 4 in Supplementary Material 4).
The final multivariable model (model 4 adjusted for the
significant confounders) is shown in Table 5. Physical and
daily living needs had the largest association with Global
health/QoL: Someone who experienced at least one severe
or moderate unmet physical and daily living need had on
average a 15.1-point (CI [− 19.45; − 10.79]) decreased
Global health/QoL score compared with someone without
an unmet need within this SCNS domain. Unmet psycho-
logical need and health system and information also had
large associations with Global health/QoL.
Sensitivity analysis
Although the distribution of residuals in the linear regression
model for QLQ-C30 Global health/QoL met the normality
assumption, we additionally tested whether outliers biased
the association between the outcome and the SCNS domains.
The regression model excluding seven outliers provided sim-
ilar results for the SCNS domains (see Supplementary
Material 6: Table 6.1, Model 1).
Table 4 Multivariable logistic
regression models of at least one
moderate or severe unmet need
for each SCNS domain at
15 months, baseline covariates
Independent (baseline) variables OR (OR 95% CI)
Model 1: high physical and daily living needs
Unemployed/retired (ref: employed) 3.82** (1.43; 10.23)
At least one comorbidity (ref: none) 2.74* (1.12; 6.71)
QLQ-C30 role functioning problem (ref: no problem) 2.66** (1.33; 5.31)
QLQ-CR29 fatigue problem (ref: no problem) 4.17*** (1.98; 8.81)
QLQ-CR29 buttock pain problem (ref: no problem) 4.24*** (1.88; 9.54)
QLQ-CR29 body image problem (ref: no problem) 2.29* (1.17; 4.48)
Model 2: high psychological needs
Adjuvant therapy (ref: no) 3.74*** (1.98; 7.10)
QLACS-GSS score 1.02*** (1.01; 1.03)
QLQ-C30 role functioning problem (ref: no problem) 3.17*** (1.72; 5.82)
QLQ-CR29 buttock pain problem (ref: no problem) 3.57** (1.62; 7.87)
QLQ-CR29 body image problem (ref: no problem) 2.31* (1.21; 4.42)
Model 3: high sexuality needs
Women (ref: men) 0.18** (0.07; 0.51)
Low/moderate self-efficacy (Lorig) (ref: (very) confident) 2.32* (1.03; 5.21)
QLQ-CR29 buttock pain problem (ref: no problem) 3.11* (1.22; 7.91)
QLQ-CR29 body image problem (ref: no problem) 3.59** (1.60; 8.07)
QLQ-CR29 dysuria problem (ref: no problem) 10.04* (1.46; 69.02)
Model 4: high patient care and support needs
QLQ-C30 Global health/quality of life score 0.97** (0.95; 0.99)
QLQ-CR29 body image problem (ref: no problem) 5.44*** (2.33; 12.69)
QLQ-CR29 blood or mucus in stool (ref: no problem) 7.50** (2.03; 27.74)
Model 5: high health system and information needs
Adjuvant therapy (ref: no) 2.17* (1.14; 4.16)
QLQ-C30 blood or mucus in stool (ref: no problem) 7.41** (2.13; 25.72)
QLQ-CR29 body image problem (ref: no problem) 5.27*** (2.74; 10.12)
Each model is adjusted for age of respondents
*p < 0.05; **p < 0.01; ***p < 0.001
Abbreviations:QLQ-C30, EORTCQLQ-C30;QLQ-CR29, EORTCQLQ-CR29;QLACS-GSS, Quality of Life in
Adult Cancer Survivors Generic Summary Score; Lorig, The Self-efficacy for Managing Chronic Disease Scale
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Discussion
This study found that 43% of people who have undergone
surgery for CRC still have unmet needs 15 months later (mod-
erate or severe for 25%) and these needs persist at 24 months.
Poor HRQoL, measured shortly after diagnosis, was predic-
tive of unmet needs following treatment thus the capture of
HRQoL data, as part of a comprehensive assessment around
the time of diagnosis, would help identify those at risk of
unmet needs. Furthermore, after treatment had finished, hav-
ing an unmet need, particularly with respect to physical or
daily living aspects, psychological and health system and in-
formation was associated with poorer global HRQoL and
health status.
Compared with previous research using the SCNS SF-34
with mixed cancer cohorts [16, 21, 22, 26], our sample report-
ed fewer unmet needs. In a study by McDowell et al. [22],
unmet needs were reported by approximately two-thirds of
cancer patients (with mixed tumour types) at the end of treat-
ment, and half at 6 months post-treatment. Patients in our
study also presented with fewer needs compared with CRC
patients in other studies, for example Jorgensen et al. [25]
found that unmet needs at 3 months post-surgery were report-
ed by 79% of patients aged < 65 years and 65% of patients
aged 65 years and older. However, the previous studies includ-
ed patients with more advanced disease (including those with
metastases—Dukes’ stage D). Our method for calculating per-
centages for unmet need prevalence is also more conservative
than other methods, given that we based it on the total number
in the sample, rather than just those expressing a need. In
addition, wemay have underestimated the level of unmet need
because the non-completers in our study had greater morbidity
at baseline and thus may have had the greatest need. However,
the level of attrition in our study between baseline and follow-
up assessments was low.
Despite the relatively low prevalence of moderate and se-
vere unmet need in our sample, we identified a group of pa-
tients with a high number (> 5) of moderate or severe unmet
needs: 13% of patients at the end of treatment and 16%
9 months later had at least five moderate or severe unmet
needs. It is also worth noting that there was a small proportion
(15%) of patients who reported no moderate or severe unmet
need at the end of treatment and went on to report one or more
moderate or severe unmet needs at 24 months.
The significant physical and psychological burden imposed
by cancer and its treatment is reflected in the prevalence of
unmet need within the physical and daily living needs and
psychological needs domains, and concurs with previous find-
ings [21, 26]. In line with previous findings [26, 47], we found
that patients’ worries extend beyond their own health and
future to those of other people close to them, which was iden-
tified as the fifth and sixth most prevalent unmet need for the
two respective time points.
In our study, unmet needs were assessed at a time when
treatment had ended and patients were likely to be less closely
monitored and have fewer opportunities to discuss and ad-
dress their concerns with healthcare professionals. Even when
patients have access to health professionals, evidence suggests
that psychological needs of patients with cancer are often
overlooked, and patientsmay perceive that their psychological
needs are unmet. Research by DiFabio et al. [48] compared
surgeons’ and patients’ evaluations of areas of need following
CRC resection. Their findings suggest that while 26% of pa-
tients identified addressing emotional problems as important,
these were not recognised as a need for attention by any of the
surgeons surveyed. In addition, health professionals might not
Table 5 Multivariable linear
regression model of QLQ-C30
Global health/QoL at 15 months,
adjusted for the significant covar-
iates from each thematic block1
Independent (at 15 months) variables Coefficient (95% CI)
Physical and daily living needs (ref: no need/low level) 0.00
Yes, high level of this domain of needs − 15.12*** (− 19.45; − 10.79)
Psychological needs (ref: no need/low level) 0.00
Yes, high level of this domain of needs − 7.33*** (− 11.61; − 3.06)
Health system and information needs (ref: no need/low level) 0.00
Yes, high level of this domain of needs − 6.25** (− 10.77; − 1.74)
Domestic status (ref: married/cohabiting) 0.00
Single/never married/divorced/widowed − 4.31** (− 7.28; − 1.34)
Comorbidities (ref: none) 0.00
Yes, at least one − 7.43*** (− 10.56; − 4.30)
Neoadjuvant therapy (ref: none) 0.00
Yes, any (chemotherapy/radiotherapy /both) − 4.23** (− 7.68; −0.79)
Had any negative life event in the last 6 months (ref: none) 0.00
Yes, at least one − 3.97** (− 6.89; − 1.05)
The model is adjusted for age of respondents; *p < 0.05; **p < 0.01; ***p < 0.001
1 See Supplementary material 4 for the significant covariates from each thematic block
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feel adequately equipped or have the time to handle psycho-
logical concerns including fear of recurrence [49]. Thus,
healthcare professionals might avoid asking about concerns
which they cannot address.
Pre-treatment characteristics were predictive of unmet
needs reported 15 months later. Notably, there was evidence
to suggest treatment type had the greatest impact on unmet
psychological needs, with patients who received adjuvant
treatment more likely to report unmet moderate or severe psy-
chological needs compared with those receiving no adjuvant
treatment. This can be explained by the greater demands
placed on patients and potential psychological effects of un-
dergoing a combined treatment regimen. We also found that
patients with a diagnosis of at least one other illness in addi-
tion to cancer had more physical unmet needs which is con-
sistent with previous findings [50] and suggests that other
diagnoses are likely to bring more physical demands.
Our findings also suggest that patients not in employment
or retired were more likely to report unmet physical and daily
living needs. Similar findings have been previously noted by
Boyes et al. [26], where patients with more physical and daily
living needs were unable to work or were older and retired.
We also found that patients who were not confident in man-
aging their illness were more likely to report unmet sexual
needs. Low self-efficacy has previously been identified as
predictive of poor QoL in this study sample [51].
To our knowledge, this study is the first to explore the
broad spectrum of HRQoL (symptoms and functioning) soon
after diagnosis as predictors of future unmet needs, with pre-
vious research often cross-sectional in nature and limited to
socio-demographic and clinical correlates of unmet needs
[25]. HRQoL scores predicted all 5 domains of unmet need
at 15 months, with poorer HRQoL scores on the symptom
scales increasing the odds of unmet need. In particular, pa-
tients with poorer body image were more likely to have unmet
needs across all domains. Impaired body image is common in
CRC and linked to potential stoma formation and changes in
bodily function following CRC surgery [52]. Studies evaluat-
ing the impact of colorectal cancer on body image tend to
focus on psychosocial functioning and sexuality concerns
[53]. Our findings suggest that body image concerns have
widespread consequences for unmet needs and underscore
the importance of attending to body image especially as the
greatest impact was on patient care and support needs.
Our findings also suggest that unresolved symptoms and
functioning issues can cause difficulties that can remain
unaddressed. For example, patients with higher scores in
terms of buttock pain had more physical, psychological,
and sexuality unmet needs. Dysuria was the greatest pre-
dictor of unmet sexuality needs while problems with blood
in mucus or stools placed patients at greater risk of unmet
patient care and support and healthcare and information
unmet needs.
Previous research has examined the association between
unmet needs and HRQoL and suggests unmet needs are a
more significant correlate of HRQoL in cancer patients than
socio-demographic or clinical characteristics [54, 55]. In ad-
dition, Husson et al. found that addressing unmet need leads to
improved HRQoL [56]. Our study confirms previous research
and suggests that moderate or severe unmet needs result in a
decreased Global health/QoL score of up to 15 points. Unmet
physical needs had the largest association with Global health/
QoL, suggesting that the assessment and treatment of physical
and daily living needs is part icularly important .
Psychological, and health system and information needs were
also significantly associated with reduced health and
wellbeing, suggesting that these are also important areas for
intervention.
Limitations
Our study includes a highly representative sample of the
eligible CRC patients from the recruitment period, with
high rates of retention. However, comparison of the par-
ticipants who remained in the study at 15 months with
baseline participants suggests the possibility of underesti-
mation of unmet need at 15 months given that those who
left the study by this point might be at risk of greater
unmet needs.
Although the study included a large number of potential
factors associated with unmet need and HRQoL, some factors
were under-represented in the analyses because of low preva-
lence or high rates of missing data. Other potential key vari-
ables such as specific coping styles and level of physical ac-
tivity which have previously been explored and identified as
playing a significant role [26], were not included in the
analyses.
It would have been valuable to carry out a needs assess-
ment at diagnosis as has been done in a previous study [24].
However, we could determine whether patients had ever had
the need, whether the need was satisfied or whether there is an
outstanding need for support. For the majority of patients,
needs were identified as not applicable suggesting they had
never required help. In addition, extending the timeframe of
SCNS SF-34 assessment points following treatment might
have provided greater scope for a reduction of unmet needs.
For example, it is possible that sexuality needs are not ad-
dressed until later on in the illness continuum. Future research
should continue to measure supportive care needs over a more
prolonged period of time.
Finally, while we measured supportive care needs using a
well-validated instrument (SCNS SF-34), it is possible that
certain needs might have been overlooked. Thereby, the
SCNS SF-34 may not fully capture the unique needs of pa-
tients with CRC in the early phase following treatment.
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Conclusion
About a quarter of our sample of patients with CRC reported
persistent moderate or severe unmet needs at the end of treat-
ment, particularly related to psychological and physical con-
cerns. Supportive care services should target those at risk of
prolonged high unmet needs, and the implementation of
personalised and tailored services are likely to confer
HRQoL gains. Our findings suggest that identification of vul-
nerable patients should look beyond socio-demographic and
clinical parameters and include an evaluation of patients’
HRQoL at the beginning of treatment. Assessment and care
planning in response to unmet needs should be integrated into
personalised survivorship care.
Acknowledgements We thank all CREW study participants, recruiting
hospitals, research partners, andMacmillan Survivorship Research Group
staff (past and present) who have been involved with CREW. Study
Advisory Committee: Jo Armes, Janis Baird, Andrew Bateman, Nick
Beck, Graham Moon, Claire Hulme, Karen Poole, Susan Restorick-
Banks, Alison Richardson (Chair), Paul Roderick, Claire Taylor,
Jocelyn Walters, and Fran Williams.
Funding information The study was funded by Macmillan Cancer
Support as part of the Macmillan Survivorship Research Group pro-
gramme (Chief Investigator: CF; grant number 3546834). CF, SCS,
SW, NVP, MP, LC, and AD were funded by the Macmillan
Survivorship Research Group. DF was funded by the Macmillan
Survivorship Research Group during recruitment for CREW and subse-
quently by the University of Southampton. AR and PWFS were funded
by the University of Southampton. JW was funded by University
Hospital Southampton NHS Foundation Trust. JC was funded by the
University of Southampton and subsequently University of Nottingham.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval All procedures performed in studies involving human
participants were in accordance with the ethical standards of the institu-
tional and/or national research committee and with the 1964 Helsinki
Declaration and its later amendments or comparable ethical standards.
Informed consent Informed consent was obtained from all individual
participants involved in the study.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Snyder CF, Aaronson NK. Use of patient-reported outcomes in
clinical practice. Lancet. 2009;374(9687):369–70.
2. U.S. Department of Health and Human Services Food and Drug
Administration, Guidance for industry - patient-related outcome
measures: use in medical product development for support labelling
claims. December 2009. Silver Spring,MD: FDA. https://www.fda.
gov/downloads/drugs/guidances/ucm193282.pdf.
3. Warrington L, Absolom K, Velikova G. Integrated care pathways
for cancer survivors - a role for patient-reported outcome measures
and health informatics. Acta Oncol. 2015;54(5):600–8.
4. Basch E. Patient-reported outcomes - harnessing patients’ voices to
improve clinical care. N Engl J Med. 2017;376(2):105–8.
5. Viola KV. Surgical perspectives in gastrointestinal disease: a study
of quality of life outcomes in esophageal, pancreatic, colon, and
rectal cancers. World J Gastroenterol. 2006;12(20):6594–601.
6. Macmillan Cancer Support. Throwing light on the consequences of
cancer and its treatment. 2013. http://www.macmillan.org.uk/
documents/aboutus/research/researchandevaluationreports/
throwinglightontheconsequencesofcanceranditstreatment.pdf2013.
Accessed 29 Jan 2018.
7. Maddams J, UtleyM,Moller H. Projections of cancer prevalence in
the United Kingdom, 2010-2040. Br J Cancer. 2012;107(7):1195–
202.
8. Walters S, Nur U, Rachet B, Gordon E, Jakomis N, Edgar G et al.
Cancer survival in England: one-year and five-year survival for 21
common cancers, by sex and age. Patients diagnosed 2003-2007
and followed up to 2008. In Statistical bulletin: cancer survival in
England. 2011, Newport.
9. Solomon T, Rachet B, Whitehead S, Coleman MP. Cancer survival
in England: patients diagnosed 2007-2011 and followed up to 2012.
In Statistical bulletin: Cancer survival in England. 2013. Newport.
10. Morris E, Quirke P, Thomas JD, Fairley L, Cottier B, Forman D.
Unacceptable variation in abdominoperineal excision rates for rec-
tal cancer: time to intervene? Gut. 2008;57(12):1690–7.
11. Foster C, Wright D, Hill H, Hopkinson J, Roffe L. Psychosocial
implications of living 5 years or more following a cancer diagnosis:
a systematic review of the research evidence. Eur J Cancer Care
(Engl). 2009;18(3):223–47.
12. Jansen L, Koch L, Brenner H, Arndt V. Quality of life among long-
term (>/=5 years) colorectal cancer survivors–systematic review.
Eur J Cancer. 2010;46(16):2879–88.
13. Ramsey SD, Berry K, Moinpour C, Giedzinska A, Andersen MR.
Quality of life in long term survivors of colorectal cancer. Am J
Gastroenterol. 2002;97(5):1228–34.
14. Brearley SG, Stamataki Z, Addington-Hall J, Foster C, Hodges L,
Jarrett N, et al. The physical and practical problems experienced by
cancer survivors: a rapid review and synthesis of the literature. Eur J
Oncol Nurs. 2011;15(3):204–12.
15. Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A.
Evaluation of an instrument to assess the needs of patients with cancer.
Supportive care review group. Cancer. 2000;88(1):217–25.
16. Boyes A, Girgis A, Lecathelinais C. Brief assessment of adult can-
cer patients’ perceived needs: development and validation of the
34-item supportive care needs survey (SCNS-SF34). J Eval Clin
Pract. 2009;15(4):602–6.
17. Boberg EW, Gustafson DH, Hawkins RP, Offord KP, Koch C, Wen
KY, et al. Assessing the unmet information, support and care deliv-
ery needs of men with prostate cancer. Patient Educ Couns.
2003;49(3):233–42.
18. McIllmurray MB, Thomas C, Francis B, Morris S, Soothill K, Al-
Hamad A. The psychosocial needs of cancer patients: findings from
an observational study. Eur J Cancer Care (Engl). 2001;10(4):261–
9.
19. Hodgkinson K, Butow P, Fuchs A, Hunt GE, Stenlake A, Hobbs
KM, et al. Long-term survival from gynecologic cancer: psychoso-
cial outcomes, supportive care needs and positive outcomes.
Gynecol Oncol. 2007;104(2):381–9.
J Cancer Surviv
20. Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM,
Wain G. Breast cancer survivors’ supportive care needs 2-10 years
after diagnosis. Support Care Cancer. 2007;15(5):515–23.
21. Armes J, CroweM, Colbourne L, Morgan H, Murrells T, Oakley C,
et al. Patients’ supportive care needs beyond the end of cancer
treatment: a prospective, longitudinal survey. J Clin Oncol.
2009;27(36):6172–9.
22. McDowell ME, Occhipinti S, Ferguson M, Dunn J, Chambers SK.
Predictors of change in unmet supportive care needs in cancer.
Psychooncology. 2010;19(5):508–16.
23. Richardson A, Medina J, Brown V, Sitzia J. Patients’ needs assess-
ment in cancer care: a review of assessment tools. Support Care
Cancer. 2007;15(10):1125–44.
24. Lam WWT, LawWL, Poon JTC, Fong D, Girgis A, Fielding R. A
longitudinal study of supportive care needs among Chinese patients
awaiting colorectal cancer surgery. Psycho-Oncology. 2016;25(5):
496–505.
25. Jorgensen ML, Young JM, Harrison JD, Solomon MJ. Unmet sup-
portive care needs in colorectal cancer: differences by age. Support
Care Cancer. 2012;20(6):1275–81.
26. Boyes AW, Girgis A, D'Este C, Zucca AC. Prevalence and corre-
lates of cancer survivors’ supportive care needs 6 months after
diagnosis: a population-based cross-sectional study. BMC Cancer.
2012;12:150.
27. Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook
P. The unmet supportive care needs of patients with cancer.
Supportive Care Review Group. Cancer. 2000;88(1):226–37.
28. Lintz K, Moynihan C, Steginga S, Norman A, Eeles R, Huddart R,
et al. Prostate cancer patients' support and psychological care needs:
survey from a non-surgical oncology clinic. Psychooncology.
2003;12(8):769–83.
29. Thewes B, Butow P, Girgis A, Pendlebury S. Assessment of unmet
needs among survivors of breast cancer. J Psychosoc Oncol.
2004;22(1):51–73.
30. Hwang SY, Park BW. The perceived care needs of breast cancer
patients in Korea. Yonsei Med J. 2006;47(4):524–33.
31. Ream E, Quennell A, Fincham L, Faithfull S, Khoo V, Wilson-
Barnett J, et al. Supportive care needs of men living with prostate
cancer in England: a survey. Br J Cancer. 2008;98(12):1903–9.
32. Shun SC, Yeh KH, Liang JT, Huang J, Chen SC, Lin BR, et al.
Unmet supportive care needs of patients with colorectal cancer:
significant differences by type D personality. Oncol Nurs Forum.
2014;41(1):E3–11.
33. Fenlon D, Richardson A, Addington-Hall J, Smith P, Corner J,
Winter J, et al. A cohort study of the recovery of health and
wellbeing following colorectal cancer (CREW study): protocol pa-
per. BMC Health Serv Res. 2012;12:90.
34. Foster C, Fenlon D. Recovery and self-management support following
primary cancer treatment. Br J Cancer. 2011;105(Suppl 1):S21–8.
35. Brugha TS, Cragg D. The list of threatening experiences: the reli-
ability and validity of a brief life events questionnaire. Acta
Psychiatr Scand. 1990;82(1):77–81.
36. The EuroQol Group. EuroQol-a new facility for the measurement
of health-related quality of life. Health Policy. 1990;16(3):199–208.
37. Avis NE, Smith KW, McGraw S, Smith RG, Petronis VM, Carver
CS. Assessing quality of life in adult cancer survivors (QLACS).
Qual Life Res. 2005;14(4):1007–23.
38. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A,
Duez NJ, et al. The European Organization for Research and
Treatment of Cancer QLQ-C30: a quality-of-life instrument for
use in international clinical trials in oncology. J Natl Cancer Inst.
1993;85(5):365–76.
39. Gujral S, Conroy T, Fleissner C, S O, King PM, Avery KN, et al.
European Organisation for Research and Treatment of Cancer
Quality of Life Group Assessing quality of life in patients with
colorectal cancer: an update of the EORTC quality of life question-
naire. Eur J Cancer. 2007;43(10):1564–73.
40. The International Wellbeing Group. Personal Wellbeing Index -
Adult (PWI-A). 5th edition 2013, Melbourne: The Australian
Centre on Quality of Life, Deakin University (http://www.deakin.
edu.au/research/acqol/instruments/wellbeing-index/index.php).
Accessed 29 Jan 2018.
41. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA.
Manual for the state-trait anxiety inventory (STAI). Palo Alto:
Consulting Psychologists Press; 1983.
42. Radloff LS. The CES-D scale: a self report depression scale for
research in the general population. Appl Psychol Measur. 1977;1:
385–401.
43. Thompson ER. Development and validation of an internationally
reliable short-form of the positive and negative affect schedule
(Panas). J Cross-Cult Psychol. 2007;38(2):227–42.
44. Sherbourne CD, Stewart AL. The MOS social support survey. Soc
Sci Med. 1991;32(6):705–14.
45. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a
self-management program on patients with chronic disease. Eff Clin
Pract. 2001;4(6):256–62.
46. Cummings A, Grimmett C, Calman L, Patel M, Permyakova NV,
Winter J, et al. Comorbidities are associated with poorer quality of
life and functioning and worse symptoms in the 5 years following
colorectal cancer surgery: results from the ColoREctal Well-being
(CREW) cohort study. Psychooncology. 2018;27(10):2427–35.
47. Sakamoto N, Takiguchi S, Komatsu H, Okuyama T, Nakaguchi T,
Kubota Y, et al. Supportive care needs and psychological distress
and/or quality of life in ambulatory advanced colorectal cancer
patients receiving chemotherapy: a cross-sectional study. Jpn J
Clin Oncol. 2017;47(12):1157–61.
48. Di Fabio FKM, Nascimbeni R, Talarico C, Salerni B. Long-term
outcome after colorectal cancer resection. Patients’ self-reported
quality of life, sexual dysfunction and surgeons’ awareness of pa-
tients’ needs. Tumori. 2008;94(1):30–5.
49. O ‘Sullivan D, Mansour M. The nurse’s role in managing the psy-
chological and emotional impact on women diagnosed with breast
cancer. Clin Nurs Stud. 2015;3(4):29.
50. Siu M, Catton P, Jones J, Jadad AR. A pilot study examining the
unmet needs of cancer survivors living with polypathology. Curr
Oncol. 2013;20(3):e266–9.
51. Foster C, Haviland J, Winter J, Grimmett C, Chivers Seymour K,
Batehup L, et al. Pre-surgery depression and confidence to manage
problems predict recovery trajectories of health and wellbeing in the
first two years following colorectal cancer: results from the CREW
cohort study. PLoS One. 2016;11(5):e0155434.
52. Taylor C. Body image concerns after colorectal cancer surgery. Br J
Nurs. 2015;24(10):S8 S10-2, S4.
53. Reese JB, Handorf E, Haythornthwaite JA. Sexual quality of life,
body image distress, and psychosocial outcomes in colorectal can-
cer: a longitudinal study. Support Care Cancer. 2018;26(10):3431–
40.
54. Okediji PT, Salako O, Fatiregun OO. Pattern and predictors of
unmet supportive care needs in cancer patients. Cureus.
2017;9(5):e1234.
55. Park BW, Hwang SY. Unmet needs and their relationship with
quality of life among women with recurrent breast cancer. J
Breast Cancer. 2012;15(4):454–61.
56. Husson O, Mols F, van de Poll-Franse LV. The relation between
information provision and health-related quality of life, anxiety and
depression among cancer survivors: a systematic reviecw. Ann
Oncol. 2011;22(4):761–72.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
J Cancer Surviv
